SCHEMBL7014171

SCHEMBL7014171

CCOC(=O)c1nc2c(N)cc(C)cn2c1C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.42
ADORA2A P29274 3/20 0.42
ADORA1 P30542 3/20 0.42
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39
RCE1 Q9Y256 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ELANE P08246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353312 0.81 SMN1; SMN2 (0.53) ALDH1A1CYP1A2KDM4EHPGDNPC1
SCHEMBL6354319 0.78 SMN1; SMN2 (0.50) ADORA3ADORA2AADORA1ALDH1A1CYP1A2
SCHEMBL31040054 0.76 ADORA3 (0.41) ADORA3ADORA2AADORA1ALDH1A1CYP1A2
SCHEMBL4169299 0.76 SMN1; SMN2 (0.44) ALDH1A1CYP1A2KDM4EHPGDRAB9A
SCHEMBL29772638 0.74 SMN1; SMN2 (0.39) ADORA3ADORA2AADORA1ALDH1A1CYP1A2
SCHEMBL31065500 0.74 MAPT (0.40) ADORA3ADORA2AADORA1ALDH1A1CYP1A2
SCHEMBL7013061 0.74 CYP3A4 (0.51) CYP1A2CYP2D6CYP2C19
SCHEMBL13090307 0.71 POLB (0.40) ALDH1A1CYP1A2KDM4EHPGDPOLB
SCHEMBL2681486 0.71 GABRP (0.43) ADORA3ALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL5634670 0.69 SMN1; SMN2 (0.59) ADORA3ADORA2AADORA1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613775-B1 8-(2,6-dimethylbenzylamino)-2-hydroxymethyl-3-methylimidazo(1, 2-a)pyridine used as antisecretory agents for prophylaxis of gastrointestinal disorders such as ulcers ASTRAZENECA AB (SE) 2003-09-02 US disclosed
EP-1105390-B1 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases ASTRAZENECA AB (SE) 2003-06-04 EP disclosed